“dexamethasone” Archives

in
Entry Author Date Location
Bio Roundup: A Royal IPO, Akili Arrives, Orca Bio Surfaces & More 06/19/20 National
FDA Staff Hammers Karyopharm Cancer Drug on Safety, Efficacy Concerns 02/22/19 Boston
BCMA Day: At ASH ‘18, Cell Therapies For Myeloma Take Center Stage 12/04/18 National
Bio Roundup: Lung Cancer Questions, Migraine Races, HIV Battle & More 02/09/18 National
Ocular Therapeutix Hit by Subpoena, SEC Seeks Eye Pain Drug Documents 12/22/17 Boston
Otonomy Scraps Hearing Loss Drug After Phase 3 Flop, Shares Routed 08/30/17 San Diego
Latest Immunotherapy Setback: Bristol Drugs Stumble in Kidney Cancer 08/16/17 New York
Mattessich Starts as New Ocular CEO, Trims Staff in Cost-Saving Move 08/02/17 Boston
FDA Halts Merck’s Multiple Myeloma Trials After Patient Deaths 07/05/17 New York
In a Myeloma Setback, Merck Halts Studies Due to Patient Deaths 06/12/17 New York
Silatronix, Propeller, BrainXell, & More: This Week’s WI Watchlist 11/08/16 Wisconsin
Celgene Passes on Acetylon as Another Option-to-Buy Deal Flames Out 08/08/16 Boston
Ocular’s Shares Fall After Eye Treatment Fails Latest Test 06/06/16 Boston
Shire Snaps up New York’s Foresight Bio in $300M Pink Eye Deal 08/03/15 New York
East Coast Biotech Roundup: Cellectis, Bristol, What’s Hot & More 04/13/15 Boston
East Coast Biotech Roundup: Sync Project, Epizyme, Bristol & More 03/16/15 Boston
Ocular’s Long-Lasting Eye Drug Tech Passes First Late-Stage Test 03/10/15 Boston
East Coast Biotech Roundup: Vertex, Syndax, Build-to-Buy Deals & More 02/20/15 Boston
Tesaro Climbs on Phase 3 Data for Nausea Drug 05/12/14 Boston
Otonomy Raises $49M to Advance 3 Drugs for Treating Ear Diseases 04/30/14 San Diego
Otonomy Drug Could Have Broader Potential Application for Hearing Loss 02/22/11 San Diego
Page 1 of 1